RRM1 and cholangiocarcinoma: Previous studies reported RRM1 as a potential predictive biomarker of gemcitabine in CCA, the expression of RRM1 in this study, however, did not show an association with chemotherapy response, limiting its use as a predictive biomarker of GP chemotherapy efficacy [24,27].